Literature DB >> 16156141

Intravitreal bevacizumab for choroidal neovascularization and cystoid macular edema: a cost-effective treatment?

Elias Reichel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16156141

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN： 1542-8877


× No keyword cloud information.
  4 in total

Review 1.  Some ethical considerations for the "off-label" use of drugs such as Avastin.

Authors:  D Wong; G Kyle
Journal:  Br J Ophthalmol       Date:  2006-10       Impact factor: 4.638

2.  Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells.

Authors:  Swaantje Peters; Sylvie Julien; Peter Heiduschka; Salvatore Grisanti; Focke Ziemssen; Martin Adler; Ulrich Schraermeyer; Karl-Ulrich Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

3.  Intravitreal bevacizumab (Avastin) treatment of neovascular glaucoma in ocular ischemic syndrome.

Authors:  Sang Joon Lee; Jung Joo Lee; Soo Young Kim; Shin Dong Kim
Journal:  Korean J Ophthalmol       Date:  2009-06-09

4.  Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

Authors:  S Aisenbrey; F Ziemssen; M Völker; F Gelisken; P Szurman; G Jaissle; S Grisanti; K U Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12-21       Impact factor: 3.535
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.